Pachydermoperiostosis Presenting With End-Stage Kidney Disease

被引:1
|
作者
Ghai, Hunar K. [1 ]
Suresh, Sandhya [2 ]
Elumalai, Ram Prasad [2 ]
机构
[1] Sri Ramachandra Inst Higher Educ & Res, Gen Med, Chennai, India
[2] Sri Ramachandra Inst Higher Educ & Res, Nephrol, Chennai, India
关键词
end-stage renal disease (esrd); complementary and alternative medicines; osteoarthropathy; etoricoxib; pachydermoperiostosis; MUTATIONS;
D O I
10.7759/cureus.62408
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pachydermoperiostosis, also known as Touraine-Solente-Gol & eacute; syndrome, is an uncommon hereditary condition. This condition includes skin thickening (pachydermia), abnormalities of the bones (periostosis), and digital clubbing (acropachy). We present a case of complete pachydermoperiostosis who presented with end -stage kidney disease. Chronic tubulointerstitial disease secondary to long-term analgesics and complementary and alternative medications was considered the likely etiology for renal dysfunction. The patient underwent serial hemodialysis followed by arteriovenous fistula surgery. In view of significant synovial inflammation, he was also given a selective COX -2 inhibitor. Pachydermoperiostosis is a rare condition, and although there is no therapy for the condition itself, medicinal or surgical interventions can effectively control its secondary effects.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] End-Stage Kidney Disease Without Dialysis
    Moss, Alvin H.
    Armistead, Nancy
    Lupu, Dale
    HEALTH AFFAIRS, 2015, 34 (11)
  • [22] Caring for patients with end-stage kidney disease
    Bates, Jane
    Chitani, Alex
    Dreyer, Gavin
    LANCET, 2015, 386 (9996): : 854 - 855
  • [23] Palliative care in end-stage kidney disease
    Fassett, Robert G.
    Robertson, Iain K.
    Mace, Rose
    Youl, Loren
    Challenor, Sarah
    Bull, Rosalind
    NEPHROLOGY, 2011, 16 (01) : 4 - 12
  • [24] Cancer Screening in End-Stage Kidney Disease
    Shirazian, Shayan
    Starakiewicz, Piotr
    Latcha, Sheron
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2021, 28 (05) : 502 - +
  • [25] Hematuria and risk for end-stage kidney disease
    Vivante, Asaf
    Calderon-Margalit, Ronit
    Skorecki, Karl
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2013, 22 (03): : 325 - 330
  • [26] Endotoxin detection in end-stage kidney disease
    Wong, Jonathan
    Jeraj, Hassan
    Vilar, Enric
    Viljoen, Adie
    Farrington, Ken
    JOURNAL OF CLINICAL PATHOLOGY, 2015, 68 (01) : 73 - 78
  • [27] Novel coronavirus disease in patients with end-stage kidney disease
    Shimada, Noriaki
    Shimada, Hiroaki
    Itaya, Yoshiaki
    Tomino, Yasuhiko
    THERAPEUTIC APHERESIS AND DIALYSIS, 2021, 25 (05) : 544 - 550
  • [28] END-STAGE RENAL DISEASE AND CHRONIC KIDNEY DISEASE IN BRAZIL
    Lugon, Jocemir R.
    ETHNICITY & DISEASE, 2009, 19 (01) : 7 - 9
  • [29] Ischemic Heart Disease in Patients with End-Stage Kidney Disease
    Tanaka, Yuri
    Joki, Nobuhiko
    Hase, Hiroki
    BLOOD PURIFICATION, 2015, 40 (04) : 332 - 336
  • [30] Role of haptoglobin phenotype in end-stage kidney disease
    Burbea, Z
    Nakhoul, F
    Rosenberg, S
    Zoabi, R
    Skorecki, K
    Hochberg, I
    Miller-Lotan, R
    Benchetrit, S
    Weissgarten, J
    Knecht, A
    Tovbin, D
    Levy, NS
    Levy, AP
    NEPHRON EXPERIMENTAL NEPHROLOGY, 2004, 97 (02): : E71 - E76